Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

被引:179
作者
Pascal, Kristen E. [1 ]
Coleman, Christopher M. [2 ]
Mujica, Alejandro O. [1 ]
Kamat, Vishal [1 ]
Badithe, Ashok [1 ]
Fairhurst, Jeanette [1 ]
Hunt, Charleen [1 ]
Strein, John [1 ]
Berrebi, Alexander [3 ]
Sisk, Jeanne M. [2 ]
Matthews, Krystal L. [2 ]
Babb, Robert [1 ]
Chen, Gang [1 ]
Lai, Ka-Man V. [1 ]
Huang, Tammy T. [1 ]
Olson, William [1 ]
Yancopoulos, George D. [1 ]
Stahl, Neil [1 ]
Frieman, Matthew B. [2 ]
Kyratsous, Christos A. [1 ]
机构
[1] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[2] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
关键词
MERS-CoV; Spike; DPP4; neutralizing antibody; mouse model; RESPIRATORY SYNDROME CORONAVIRUS; DIPEPTIDYL PEPTIDASE 4; NEUTRALIZING ANTIBODIES; IMMUNOGLOBULIN GENES; FUNCTIONAL RECEPTOR; SAUDI-ARABIA; MICE; REPLICATION; GENERATION; VIRUS;
D O I
10.1073/pnas.1510830112
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Traditional approaches to antimicrobial drug development are poorly suited to combatting the emergence of novel pathogens. Additionally, the lack of small animal models for these infections hinders the in vivo testing of potential therapeutics. Here we demonstrate the use of the VelocImmune technology (a mouse that expresses human antibody-variable heavy chains and. light chains) alongside the VelociGene technology (which allows for rapid engineering of the mouse genome) to quickly develop and evaluate antibodies against an emerging viral disease. Specifically, we show the rapid generation of fully human neutralizing antibodies against the recently emerged Middle East Respiratory Syndrome coronavirus (MERS-CoV) and development of a humanized mouse model for MERS-CoV infection, which was used to demonstrate the therapeutic efficacy of the isolated antibodies. The VelocImmune and VelociGene technologies are powerful platforms that can be used to rapidly respond to emerging epidemics.
引用
收藏
页码:8738 / 8743
页数:6
相关论文
共 43 条
[1]   Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses [J].
Adedeji, Adeyemi O. ;
Singh, Kamalendra ;
Kassim, Ademola ;
Coleman, Christopher M. ;
Elliott, Ruth ;
Weiss, Susan R. ;
Frieman, Matthew B. ;
Sarafianos, Stefan G. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) :4894-4898
[2]   Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease [J].
Agrawal, Anurodh Shankar ;
Garron, Tania ;
Tao, Xinrong ;
Peng, Bi-Hung ;
Wakamiya, Maki ;
Chan, Teh-Sheng ;
Couch, Robert B. ;
Tseng, Chien-Te K. .
JOURNAL OF VIROLOGY, 2015, 89 (07) :3659-3670
[3]   Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus [J].
Assiri, Abdullah ;
McGeer, Allison ;
Perl, Trish M. ;
Price, Connie S. ;
Al Rabeeah, Abdullah A. ;
Cummings, Derek A. T. ;
Alabdullatif, Zaki N. ;
Assad, Maher ;
Almulhim, Abdulmohsen ;
Makhdoom, Hatem ;
Madani, Hossam ;
Alhakeem, Rafat ;
Al-Tawfiq, Jaffar A. ;
Cotten, Matthew ;
Watson, Simon J. ;
Kellam, Paul ;
Zumla, Alimuddin I. ;
Memish, Ziad A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05) :407-416
[4]   Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection [J].
Cockrell, Adam S. ;
Peck, Kayla M. ;
Yount, Boyd L. ;
Agnihothram, Sudhakar S. ;
Scobey, Trevor ;
Curnes, Nicole R. ;
Baric, Ralph S. ;
Heise, Mark T. .
JOURNAL OF VIROLOGY, 2014, 88 (09) :5195-5199
[5]   Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice [J].
Coleman, Christopher M. ;
Liu, Ye V. ;
Mu, Haiyan ;
Taylor, Justin K. ;
Massare, Michael ;
Flyer, David C. ;
Glenn, Gregory M. ;
Smith, Gale E. ;
Frieman, Matthew B. .
VACCINE, 2014, 32 (26) :3169-3174
[6]   Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus [J].
Coleman, Christopher M. ;
Matthews, Krystal L. ;
Goicochea, Lindsay ;
Frieman, Matthew B. .
JOURNAL OF GENERAL VIROLOGY, 2014, 95 :408-412
[7]   Emergence of the Middle East Respiratory Syndrome Coronavirus [J].
Coleman, Christopher M. ;
Frieman, Matthew B. .
PLOS PATHOGENS, 2013, 9 (09)
[8]   Spread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus [J].
Cotten, Matthew ;
Watson, Simon J. ;
Zumla, Alimuddin I. ;
Makhdoom, Hatem Q. ;
Palser, Anne L. ;
Ong, Swee Hoe ;
Al Rabeeah, Abdullah A. ;
Alhakeem, Rafat F. ;
Assiri, Abdullah ;
Al-Tawfiq, Jaffar A. ;
Albarrak, Ali ;
Barry, Mazin ;
Shibl, Atef ;
Alrabiah, Fahad A. ;
Hajjar, Sami ;
Balkhy, Hanan H. ;
Flemban, Hesham ;
Rambaut, Andrew ;
Kellam, Paul ;
Memish, Ziad A. .
MBIO, 2014, 5 (01)
[9]   Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study [J].
Cotten, Matthew ;
Watson, Simon J. ;
Kellam, Paul ;
Al-Rabeeah, Abdullah A. ;
Makhdoom, Hatem Q. ;
Assiri, Abdullah ;
Al-Tawfiq, Jaffar A. ;
Alhakeem, Rafat F. ;
Madani, Hossam ;
AlRabiah, Fahad A. ;
Al Hajjar, Sami ;
Al-Nassir, Wafa N. ;
Albarrak, Ali ;
Flemban, Hesham ;
Balkhy, Hanan H. ;
Alsubaie, Sarah ;
Palser, Anne L. ;
Gall, Astrid ;
Bashford-Rogers, Rachael ;
Rambaut, Andrew ;
Zumla, Alimuddin I. ;
Memish, Ziad A. .
LANCET, 2013, 382 (9909) :1993-2002
[10]   Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture [J].
de Wilde, Adriaan H. ;
Jochmans, Dirk ;
Posthuma, Clara C. ;
Zevenhoven-Dobbe, Jessika C. ;
van Nieuwkoop, Stefan ;
Bestebroer, Theo M. ;
van den Hoogen, Bernadette G. ;
Neyts, Johan ;
Snijder, Eric J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) :4875-4884